| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Japan | 2 | |
| #5 | China | 1 | |
| #6 | Hong Kong | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Steroids |
| # | Name | Total Patents |
|---|---|---|
| #1 | Li Wenhui | 14 |
| #2 | Sui Jianhua | 12 |
| #3 | Li Dan | 10 |
| #4 | Wang Zhiqiang | 3 |
| #5 | Zhang Lei | 3 |
| #6 | Qi Xiangbing | 3 |
| #7 | Yan Huan | 3 |
| #8 | Peng Bo | 3 |
| #9 | Liu Yang | 2 |
| #10 | Yang Liu | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021013135A1 | A method of treating hbv infection by using anti-pre-s1 hbv antibodies | |
| WO2020156539A1 | Anti-fgf19 antibodies | |
| WO2016188386A1 | Anti-Pre-S1 HBV Antibodies | |
| EP3197459A1 | Polymeric bile acid derivatives inhibit hepatitis b and d virus and ntcp transport |